Classification
Product TypeIngredient
Product FormIndustrial enzyme preparation (powder or liquid)
Industry PositionFood Processing Aid / Food Ingredient
Market
Proteases in Chile are primarily a B2B food-processing input (enzyme preparations) supplied through import channels rather than domestic primary production. Market access risk is driven less by agricultural seasonality and more by regulatory classification (additive vs. processing aid), purity/specification conformity, and import documentation readiness. Chile’s Reglamento Sanitario de los Alimentos (RSA) anchors food-additive controls and explicitly references Codex Alimentarius for identity/purity/toxicological evaluation of additives. Import workflows for sanitary-controlled foods include the Certificado de Destinación Aduanera (CDA) and SEREMI authorization for use and disposition, which can also affect industrial food inputs when treated as sanitary-controlled merchandise.
Market RoleImport-dependent ingredient market (net importer)
Domestic RoleIndustrial input used by food and beverage manufacturers for protein modification and process performance (B2B; not a typical direct-to-consumer retail product).
Risks
Regulatory Compliance HighMisclassification or non-conformity of protease enzyme preparations under Chile’s sanitary food framework (e.g., additive vs. processing aid treatment; Codex/JECFA identity/purity expectations; labeling/declaration requirements when applicable) can lead to border holds, restricted disposition, or inability to place product on the market.Pre-align the product technical dossier to Chile RSA and Codex/JECFA anchors (specification, source organism/production method statement, contaminant controls, CoA), and confirm with the importer/customs broker whether CDA/SEREMI authorization applies to the specific shipment.
Documentation Gap MediumIf the shipment is routed through sanitary control for imported foods, missing or inconsistent CDA/SEREMI paperwork and supporting documents (invoice/transport docs, warehouse authorization, CoA/technical sheet) can delay clearance and disrupt manufacturing schedules.Use a pre-shipment document checklist mapped to CDA and SEREMI steps; ensure warehouse authorization and batch documentation are ready before vessel arrival.
Food Safety MediumEnzyme preparations can be rejected or restricted if purity/contaminant controls are insufficient (e.g., microbial contamination, toxigenicity concerns from fungal sources, or unsafe residues from carriers/diluents), especially when supporting methods and specifications are incomplete.Require JECFA-aligned specifications, supplier GMP evidence, and routine lot testing/CoA covering relevant microbiological and contaminant parameters.
Logistics LowTemperature and humidity excursions during transit or storage can reduce enzyme activity and cause out-of-spec performance on arrival, leading to customer claims or rework.Specify storage/transport conditions in contracts; use moisture-protective packaging and verify activity on receipt for high-sensitivity applications.
Sustainability- GMO transparency and production-strain traceability for fermentation-derived proteases where genetic modification is used (documentation and disclosure expectations vary by downstream customer and application).
FAQ
Which Chile regulation is the main reference point for food additive controls relevant to protease preparations?Chile’s Reglamento Sanitario de los Alimentos (RSA, Decreto Supremo N° 977) is the core framework. It includes requirements for additives and references Codex Alimentarius for identity, purity, and toxicological evaluation criteria.
What international standards does Chile’s RSA point to for additive identity and purity expectations?The RSA explicitly points to Codex Alimentarius (FAO/WHO) as the reference for identity, purity, and toxicological evaluation of additives, which is commonly used as an anchor when preparing technical dossiers for regulated food inputs.
What kind of upstream controls are expected for food enzyme preparations like proteases?JECFA general specifications emphasize using nonpathogenic, nontoxigenic, well-characterized production strains, producing under GMP, and controlling undesirable substances (including mycotoxins for relevant fungal sources), with batch-consistent production and traceability.